COSM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
COSM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cosmos Health's Enterprise Value for the quarter that ended in Sep. 2023 was $29.16 Mil. Cosmos Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-13.31 Mil. Cosmos Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2023 was -45.66%.
The historical rank and industry rank for Cosmos Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Cosmos Health was 13.79%. The lowest was -89.50%. And the median was -2.87%.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Cosmos Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Sep. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
The historical data trend for Cosmos Health's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health Annual Data | |||||||||||||||||||||
Trend | Jul13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Earnings Yield (Joel Greenblatt) % | Get a 7-Day Free Trial | -3.37 | -2.92 | 4.08 | -5.04 | -22.78 |
Cosmos Health Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Earnings Yield (Joel Greenblatt) % | Get a 7-Day Free Trial | -1.89 | -22.78 | -29.67 | -26.81 | -45.66 |
For the Medical Distribution subindustry, Cosmos Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Cosmos Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2022 is calculated as
Earnings Yield (Joel Greenblatt) | = | EBIT | / | Enterprise Value |
= | -9.09 | / | 39.921944 | |
= | -22.77 % |
Cosmos Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.31 Mil.
Cosmos Health (NAS:COSM) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.
Thank you for viewing the detailed overview of Cosmos Health's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Grigorios Siokas | 10 percent owner | 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001 |
Suhel Bhutawala | director | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Nikolaos Bardakis | officer: Chief Operating Officer | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Manfred Ziegler | director | 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604 |
Anastasios Aslidis | director | 11 CANTERBURY LANE, WATCHUNG NJ 07069 |
Pavlos Ignatiades | officer: Chief Operating Officer | KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236 |
Georgios Terzis | officer: Chief Financial Officer | 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121 |
Peter Goldstein | director | 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324 |
John James Hoidas | director | 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453 |
Dimitrios Goulielmos | director, 10 percent owner, officer: CEO | 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604 |
Panagiotis Tolis | director, officer: Secretary | PERICLEOUS 50 STREET, ATHENS J3 15232 |
Panagiotis Drakopoulos | director, 10 percent owner, officer: CEO | 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606 |
Vasileios Mavrogiannis | director, 10 percent owner, officer: CFO | TERTSETI 23 STREET, KESARIANI J3 16122 |
From GuruFocus
By ACCESSWIRE • 10-11-2023
By ACCESSWIRE • 10-05-2023
By ACCESSWIRE • 12-01-2023
By ACCESSWIRE • 12-20-2023
By ACCESSWIRE • 12-08-2023
By ACCESSWIRE ACCESSWIRE • 05-25-2023
By ACCESSWIRE • 08-02-2023
By ACCESSWIRE • 09-13-2023
By ACCESSWIRE ACCESSWIRE • 06-16-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.